Elsevier Science Ltd.

SHERPA: Unknown

People

  1. Boelens
    Boelens
  2. Curran
    Curran
  3. Mauguen
    Mauguen
  4. Cancio
    Cancio
  5. Kennedy
    Kennedy
  6. Khakoo
    Khakoo
  7. Mcavoy
    Mcavoy
  8. Park
    Park
  9. Ponomarev
    Ponomarev
  10. Sadelain
    Sadelain

Groups

  1. Biostatistics Service (3)
  2. Epidemiology and Biostatistics (3)
  3. Pediatrics, Department of (3)
  4. Sloan Kettering Institute Postdocs (3)
  5. Stem Cell Transplantation and Cellular Therapy Service (3)
  6. Tow Center for Developmental Oncology (TCDO) (3)
  7. Department of Medicine (2)
  8. Adult Leukemia (1)
  9. Center for Hematologic Malignancies (1)
  10. Clinical Genetics Service (1)
Search Within
  1. "2021"
Formats
  1. Meeting Abstract (3)
  2. Review (1)
Groups
  1. Biostatistics Service (3)
  2. Epidemiology and Biostatistics (3)
  3. Pediatrics, Department of (3)
  4. Sloan Kettering Institute Postdocs (3)
  5. Stem Cell Transplantation and Cellular Therapy Service (3)
  6. Tow Center for Developmental Oncology (TCDO) (3)

More Groups

People
  1. Audrey Mauguen (3)
  2. Jaap Jan Boelens (3)
  3. Kevin Curran (2)
  4. Bianca Santomasso (1)
  5. Brigitte Senechal (1)
  6. Devin Mcavoy (1)

More People

Years
  1. 2021 (4)
Publications
  1. Cytotherapy (4)

Results (4)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Options for imaging cellular therapeutics in vivo: A multi-stakeholder perspective
    Review

    Helfer, B. M.; Ponomarev, V.; Patrick, P. S.; Blower, P. J.; Feitel, A.; Fruhwirth, G. O.; Jackman, S.; Pereira Mouriè€s, L.; Park, M. V. D. Z.; Srinivas, M.; more...
    Cytotherapy (2021)

    Fulltext@MSK | Save
  • Impact of Fanconi anemia genotype on outcome after hematopoietic stem cell transplant: A single centre experience of 20 years
    Meeting Abstract

    Jain, S.; Mauguen, A.; Djavid, A. R.; Kennedy, J. A.; Smogorzewska, A.; Walsh, M.; Boelens, J. J.; Cancio, M.
    Cytotherapy (2021)

    Fulltext@MSK | Save
  • Predictors for neurotoxicity on day of infusion of chimeric antigen receptor (CAR) T cells using discovery proteomics platform
    Meeting Abstract

    Lakkaraja, M.; Hosszu, K.; McAvoy, D.; Mauguen, A.; Purdon, T. J.; Auchincloss, T.; Klein, E.; Khakoo, Y.; Santomasso, B.; Senechal, B.; more...
    Cytotherapy (2021)

    Fulltext@MSK | Save
  • Fludarabine-exposure predicts disease control following CD19-specific CAR T cell (tisagenlecleucel); A report from pediatric real-world CAR Consortium
    Meeting Abstract

    Curran, K. J.; Fabrizio, V. A.; Mauguen, A.; Boelens, J. J.; Baggott, C.; Prabhu, S.; Placenta, H.; Phillips, C. L.; Rossoff, J.; Stefanski, H.; more...
    Cytotherapy (2021)

    Fulltext@MSK | Save

    • Elsevier Science Ltd. – authorized name for: